IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Carolina Financial Corporation
Symbol: CARO
Price: Last trade $14.76
Trade Date: 12/10
Shares: 1.7 million
Underwriter(s) Raymond James, Sandler O’Neill, Keefe Bruyette & Woods
Rating=Subscription Needed
Company: Teva Pharmaceutical Industries Limited
Symbol: TEVA
Price: Last trade $63.47
Trade Date: 12/4
Shares: 53.2 million
Underwriter(s) Barclays, BofA Merrill Lynch, Citigroup, Morgan Stanley, BNP Paribas, Credit Suisse, HSBC Holdings, Mizuho Securities, RBC Capital Markets, SMBC Nikko
Rating=Subscription Needed
Company: AmSurg Corp.
Symbol: AMSG
Price: Last trade $84.06
Trade Date: 12/2
Shares: 5.5 million
Underwriter(s) SunTrust Robinson Humphrey, J.P. Morgan, BMO Capital Markets, Jefferies, Guggenheim Securities
Rating=Subscription Needed
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish